Dissecting the role of CDK4 in liposarcoma

被引：0
|
作者：
Vanni, Silvia
Gallo, Graziana
Fausti, Valentina
Miserocchi, Giacomo
Liverani, Chiara
Spadazzi, Chiara
Cocchi, Claudia
Calabrese, Chiara
De Luca, Giovanni
Bassi, Massimo
Gessaroli, Manlio
Campobassi, Angelo
Pieri, Federica
Ercolani, Giorgio
Cavaliere, Davide
Gurrieri, Lorena
Riva, Nada
Martinelli, Giovanni
Mercatali, Laura
De Vita, Alessandro
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5993
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5993
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A role for Cdk4 in angiogenesis
    Baker, Stacey J.
    CELL CYCLE, 2010, 9 (13) : 2493 - 2493
  • [2] Role of FUS-CHOP in Myxoid Liposarcoma via miR-486/CDK4 Axis
    Hao Wu
    Liming Xia
    Haichao Xu
    Biochemical Genetics, 2022, 60 : 1095 - 1106
  • [3] Role of FUS-CHOP in Myxoid Liposarcoma via miR-486/CDK4 Axis
    Wu, Hao
    Xia, Liming
    Xu, Haichao
    BIOCHEMICAL GENETICS, 2022, 60 (03) : 1095 - 1106
  • [4] Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma
    Dickson, Mark Andrew
    Keohan, Mary Louise
    Tap, William D.
    Antonescu, Cristina
    Landa, Jonathan
    Qin, Li-Xuan
    Dohrenwend, Eric Gerard
    Rathbone, Dustin
    Ustoyev, Yelena
    Condy, Mercedes M.
    Singer, Samuel
    Schwartz, Gary K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Antiproliferative Effects of CDK4/6 Inhibition in CDK4-Amplified Human Liposarcoma In Vitro and In Vivo
    Zhang, Yi-Xiang
    Sicinska, Ewa
    Czaplinski, Jeffrey T.
    Remillard, Stephen P.
    Moss, Samuel
    Wang, Yuchuan
    Brain, Christopher
    Loo, Alice
    Snyder, Eric L.
    Demetri, George D.
    Kim, Sunkyu
    Kung, Andrew L.
    Wagner, Andrew J.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (09) : 2184 - 2193
  • [6] CDK4 Amplification Predicts Recurrence of Well-Differentiated Liposarcoma of the Abdomen
    Lee, Sanghoon
    Park, Hyojun
    Ha, Sang Yun
    Paik, Kwang Yeol
    Lee, Seung Eun
    Kim, Jong Man
    Park, Jae Berm
    Kwon, Choon Hyuck David
    Joh, Jae-Won
    Choi, Yoon-La
    Kim, Sung Joo
    PLOS ONE, 2014, 9 (08):
  • [7] Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma.
    Dickson, Mark Andrew
    Koff, Andrew
    D'Angelo, Sandra P.
    Gounder, Mrinal M.
    Keohan, Mary Louise
    Kelly, Ciara Marie
    Chi, Ping
    Antonescu, Cristina R.
    Landa, Jonathan
    Qin, Li-Xuan
    Crago, Aimee Marie
    Singer, Samuel
    Tap, William D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] The Role of CDK4 in the Pathogenesis of Pancreatic Cancer
    Jiggens, Emily
    Mortoglou, Maria
    Grant, Guy H.
    Uysal-Onganer, Pinar
    HEALTHCARE, 2021, 9 (11)
  • [9] Dedifferentiated Liposarcoma and Pleomorphic Liposarcoma: A Comparative Study on FNA Cytomorphology and MDM2/CDK4 Expression
    Marino-Enriquez, A.
    Hornick, J. L.
    Cibas, E. S.
    Qian, X.
    MODERN PATHOLOGY, 2013, 26 : 97A - 97A
  • [10] Dedifferentiated Liposarcoma and Pleomorphic Liposarcoma: A Comparative Study on FNA Cytomorphology and MDM2/CDK4 Expression
    Marino-Enriquez, A.
    Hornick, J. L.
    Cibas, E. S.
    Qian, X.
    LABORATORY INVESTIGATION, 2013, 93 : 97A - 97A
12345